Led by President Jerzy Gruhn, our nine-member executive team manages our U.S. business. Each of these vastly experienced professionals leads a specific area of the business, monitoring our progress according to Novo Nordisk's Triple Bottom Line: building our business in a way that is financially profitable socially responsible and environmentally sound. The executive team has the diversity of skills, sense of purpose, and strategic vision to guide our company to consistently higher levels of success. Their combined strengths serve to cement our position as a leader in diabetes care and accelerate the growth of our biopharmaceuticals unit.
Jerzy Gruhn
President, Novo Nordisk Inc.
Phil Fornecker
Vice President, Strategic Business Operations
Jeff Frazier
Vice President, Human Resources
Andy Ajello
Vice President, National Diabetes Sales
Karsten Munk Knudsen
Vice President, Finance and Information Technology
Camille Lee
Vice President, Diabetes Marketing
Anne Phillips
Vice President, Clinical Development, Medical & Regulatory Affairs
Jim Shehan
Vice President, Legal, Government & Quality Affairs
Edward Williams
Vice President, Biopharmaceuticals
Alan Moses
Corporate Vice President, Global Chief Medical Officer
